When you advocate bringing 30 million more people health care for $500 billion less, you need to know that rapid development of less costly treatments is your only plausible strategy.
Obama will slow development of biotech, hurting not only his plan to transform health care but also doing damage to growth industries in his own political strongholds.
The guy who told us he was going to stop anti-science bias in the White House, is about to find out anti-profit bias will produce the same outcome. The good news is his polls are so low, only elective deathwish democrats will go along with this last minute change.
It's not so much the marketing, it is the gouging and predatory practices. Pfizer is one of the experts at it, but they recently got their hand slapped.
You would think a fine this large would have garnered some attention or caused some heads to roll at Pfizer, but I guess it is just part of the game - the company wins as long as they don't get caught, and us taxpayers foot the bill. Pfizer was a repeat offender during the last 10 years and the long-time President/CEO/Chairman walked away in 2006 with a $180M retirement package - now that's good business - let's all celebrate the free market rewards that Hank earned!!
Yep, they want to sell the stuff. That doesn't minimize the huge amount spent on research, even if it's for self-interested reasons. Movie companies spend too much on advertising, too, maybe it should be spent on making more Avatars :)
http://www.sciencedaily.com/releases/2008/01/080105140107.htm A new study by two York University researchers estimates the U.S. pharmaceutical industry spends almost twice as much on promotion as it does on research and development, contrary to the industry’s claim.
The researchers’ estimate is based on the systematic collection of data directly from the industry and doctors during 2004, which shows the U.S. pharmaceutical industry spent 24.4% of the sales dollar on promotion, versus 13.4% for research and development, as a percentage of US domestic sales of US$235.4 billion.
The research is co-authored by PhD candidate Marc-André Gagnon, who led the study with Joel Lexchin, a long-time researcher of pharmaceutical promotion, Toronto physician, and Associate Chair of York’s School of Health Policy & Management in the Faculty of Health.
Vicals whole concept is saving money .A faster, simpler, and a less expensive approach to pan flu vaccines.As stated by Vijay Samant at the Q 3 CC ..By the time the current pandemic ends, the government will likely have spend an excess of $2 billion, bought too much vaccine and received most of it too late to be of any value.All of these issues highlight the need for a faster, simpler, and a less expensive approach to pan flu vaccines and that’s where Vical comes in. Vical’s goal for the current pandemic is straightforward and directly related to addressing this need. We have already demonstrated our ability to advance quickly through vaccine development and pre-clinical testing. We want to expand our human safety and immunogenicity data base to better position DNA vaccines and our Vaxfectin adjuvant for serious consideration in future pandemics. And most importantly we want to achieve this goal without risking shareholder dollars where there is no assured commercial opportunity.
The old leftist arguments ignore the fact that the entire world, especially Canada, piggyback on US drug discovery. Just how many blockbuster drugs are discovered in Canada? It's the old Little Red Hen story, nobody wants to help bake the bread, they just want to eat it when its done.
Take the "obscene" profit (a strange way of thinking for a guy who posts repeatedly on hopes to obtain riches on the intellectual capital of Vical) out of the pharma and bio world and you will see capital dry up and products fail to be developed.
Someone must need these drugs, they're being used, and life expectancy is rising. The generic copy boys you want to usher in sooner as competition, have a business model based on taking market share without development costs.
I would love to see our pols tell the drug companies they can't sell to other nations at a price below the U.S. average. That would change price structure in hockey land real quick.
Boy, Big Pharma is good.
They repeat the same story again and again and pretty soon the media is repeating it again and again, too. Forget digging, researching, checking for yourself — none of the conventional techniques of journalism seem to be powerful enough to withstand Big Pharma’s daily drip-drip-drip propaganda stream.
Of course, it doesn’t help that Big Pharma’s bought-and-paid-for Washington politicians have been taught to spout the same fictions as well.
On the issue of the safety of buying drugs from Canada, the clear and indisputable facts are (1) Canada’s drug approval standards are as good, if not better, than those of the United States, and (2) no American has ever been harmed by ordering drugs online from a licensed Canadian pharmacy.
And yet, Big Pharma lies and lies and lies until actual journalists buy into their nonsense.
The same is true on the issue of high drug prices. Facts are facts, and the fact is that Americans pay a premium of about 67 percent for prescription drugs compared to residents of the rest of the world, according to PharmaTimes. There is no country in the world where residents pay as much for drugs as we are forced to pay in the United States.
Now, common sense would lead you to believe that we’re being ripped off — wouldn’t it?
Amazingly, however, the drip-drip-drip of Big Pharma disinformation has been just as effective with the price issue as with the safety issue.
Since Big Pharma knows that Americans love our freedom, and cherish (at least until recently) our free market economy, they blame the rest of the world — those socialists in Europe and elsewhere — for America’s high drug prices. They say that the rest of the world imposes price controls on drugs, which forces poor Big Pharma to charge Americans more in order to fund research and development on new medications.
And drip-drip-drip, it gets reported as fact by one news organization after another.
Oh, brother. Do you really think Big Pharma would sell drugs to the rest of the world if they weren’t making a lot of money doing it? Of course they wouldn’t. They’re doing just fine.
They’re just not making the obscene profits that they make in the United States.
Now then: do you really think Big Pharma is making obscene profits because America has a free market system? Well, if you took economics in school, one of the first things you’d learn is that an unobstructed free market tends to push down prices over time. So if this were really a free market economy when it came to drug prices, wouldn’t you assume that competition would emerge and ultimately drug prices would come down to a level that people could afford?
Well, yes, they would come down — if drug prices were actually determined by the market. But they’re not.
In truth, our government is very involved in setting the drug prices you pay. They are involved because of a patent system that allows drug companies to have monopolies on the drugs they produce — and that allows these companies to extend their monopolies virtually indefinitely by gaming the system. This gives Big Pharma all the power in establishing prices — and the consumer none.
It’s a wink-wink nod-nod system, with an FDA that has been completely defanged by “pro-market” politicians and completely corrupted by Big Pharma’s money.
Guess what? Monopolies aren’t “pro-market,” they’re anti-market.
Not only that, monopolies are un-American.
America is about competition. Let the drug companies compete — not only with Canada but with each other — and our skyrocketing drug prices will come down to earth, and fast.
Last post on this subject..